Delivery Order SPE2DB20D2014-SPE2DB26FA16A
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,905.99 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $6,190.57 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on July 17, 2025, with an ultimate completion date of July 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement...
- The Defense Logistics Agency awarded a $52,670.24 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $36,469.66 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $60,505.52 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with a completion date of September 30, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $11,055.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $13,844.92 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,543.12 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $12,207.96 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with completion scheduled for September 18, 2025. This non-set-aside, competitively awarded contract uses firm fixed pricing and is performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA16ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,545.53 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by October 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Enbrel delivery—a biologic medication commonly used for rheumatoid arthritis and other autoimmune conditions—represents routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare systems under this expansive contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 10/22/25 |